Global Cell Therapy Raw Materials Market Expected to Reach USD 48.04 Billion by 2034 [Yahoo! Finance]
Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: Yahoo! Finance
Analysis & Forecast to 2024-2034: Market By Product; By End-user; and By Region" report has been added to ResearchAndMarkets.com's offering. Market Overview The global cell therapy raw materials market is experiencing exponential growth, primarily led by the drive in addressing chronic diseases through advanced treatment modalities and innovative product introductions. The industry was valued at USD 4.32 billion in 2023 and is projected to burgeon to a market size of USD 48.04 billion by 2034, with an impressive CAGR of 24.48% from 2024-2034. Technological Advancements Fostering Growth A prime factor contributing to this market surge is the significant technological progress within the realm of cell therapy, including developments in cell culture media, which accounted for the largest segment of revenue in 2023. This growth illustrates an increased investment from key industry players in optimizing the cell therapy process. Advancements in antibodies are forecasted to witness
Show less
Read more
Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- SCbio's Life Science Accelerator, SCbioDrive, Launches Application for Inaugural Cohort [Yahoo! Finance]Yahoo! Finance
- Charles River (CRL) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures [Yahoo! Finance]Yahoo! Finance
- Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP [Yahoo! Finance]Yahoo! Finance
- Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMPBusiness Wire
- Nobel Laureate Thomas Südhof and bit.bio CEO Mark Kotter to Lead Fireside Chat on Programming Human Cells at SynBioBeta [Yahoo! Finance]Yahoo! Finance
CRL
Earnings
- 2/14/24 - Beat
CRL
Sec Filings
- 5/3/24 - Form 4
- 4/24/24 - Form DEFA14A
- 3/29/24 - Form ARS
- CRL's page on the SEC website